U.N.-Backed Diagnostics Access Initiative Announces Lower Price Of Infant HIV Testing Technologies In Partnership With Roche
U.N. News Centre: U.N.-backed initiative announces deal to sharply lower price of HIV early infant diagnosis
“A dramatic 35 percent reduction in the price for HIV early infant diagnostic technologies [Monday was] announced by the United Nations-backed Diagnostics Access Initiative, in partnership with Roche Diagnostics. … The new access price is US$ 9.40 per test. Bringing together global and regional partners, the Diagnostics Access Initiative calls for improving laboratory capacity to ensure that all people living with HIV can be linked to effective, high-quality HIV treatment services…” (7/20).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.